Skip to main content

Huff Curtis W's Form 4 filing

Ernexa Therapeutics Inc. (ERNA) · filed Dec 18, 2023

Accession no.
0000950170-23-071263
Filed
Dec 18, 2023, 9:38 PM ET
Trade date
Dec 14-15, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 0 non-derivative transactions and 6 derivative transactions. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Huff Curtis WCIK 000125012710% Owner
Freebird Partners LPCIK 000195523110% Owner
Freebird Investments LLCCIK 000197140610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 14, 2023Common Stock, par value $0.005 per shareDReturned to the companyAcquired+424,928––524,474Direct
Dec 14, 2023Common Stock, par value $0.005 per shareAGrant or awardAcquired+424,928––949,402Direct
Dec 14, 2023Common Stock, par value $0.005 per shareDReturned to the companyAcquired+524,474––424,928Direct
Dec 14, 2023Common Stock, par value $0.005 per shareAGrant or awardAcquired+524,474––949,402Direct
Dec 15, 2023Common Stock, par value $0.005 per sharePPurchaseAcquired+520,996$1.92+$999,999.72783,233Direct
Dec 15, 2023Common Stock, par value $0.005 per sharePPurchaseAcquired+1,041,992––1,991,394Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)